AVIR — ATEA PHARMACEUTICALS INC

Ownership history in Sunpointe, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which Sunpointe, LLC reported a position in ATEA PHARMACEUTICALS INC (AVIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2024 Q1)
Avg. % of fund
0.03%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 11,943 — 0% 0.01% $43K $3.57
2025 Q3 UNCHANGED 11,943 — 0% 0.01% $35K $2.90
2025 Q2 UNCHANGED 11,943 — 0% 0.02% $43K $3.60
2025 Q1 UNCHANGED 11,943 — 0% 0.02% $36K $2.99
2024 Q4 UNCHANGED 11,943 — 0% 0.02% $40K $3.35
2024 Q3 UNCHANGED 11,943 — 0% 0.03% $40K $3.35
2024 Q2 UNCHANGED 11,943 — 0% 0.03% $40K $3.31
2024 Q1 UNCHANGED 11,943 — 0% 0.05% $48K $4.04
2023 Q4 INITIATED 11,943 — — 0.05% $36K —
% of Fund (quarterly)    AVIR price (monthly, adj. close)

Other funds also holding AVIR

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 23.11% CM Management, LLC 3Y 1.07% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.85% Bain Capital Life Sciences Investors, LLC 3Y 7Y 0.68% Aldebaran Capital, LLC 3Y 0.29% Rangeley Capital, LLC 0.24% Auour Investments LLC 0.2% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.15% Opaleye Management Inc. 3Y 7Y 0.08% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01%
← Back to Sunpointe, LLC Holdings